251 related articles for article (PubMed ID: 18293085)
21. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
22. Genomic alterations associated with early stages of breast tumor metastasis.
Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Hooke JA; Love B; Shriver CD
Ann Surg Oncol; 2008 Jul; 15(7):1989-95. PubMed ID: 18401664
[TBL] [Abstract][Full Text] [Related]
23. Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays.
Caprini E; Cristofoletti C; Arcelli D; Fadda P; Citterich MH; Sampogna F; Magrelli A; Censi F; Torreri P; Frontani M; Scala E; Picchio MC; Temperani P; Monopoli A; Lombardo GA; Taruscio D; Narducci MG; Russo G
Cancer Res; 2009 Nov; 69(21):8438-46. PubMed ID: 19843862
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
[TBL] [Abstract][Full Text] [Related]
25. Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer.
Thomassen M; Tan Q; Eiriksdottir F; Bak M; Cold S; Kruse TA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5355-60. PubMed ID: 17875763
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.
Yin Y; Chen X; Shu Y
Biomed Pharmacother; 2009 Jul; 63(6):421-8. PubMed ID: 19564093
[TBL] [Abstract][Full Text] [Related]
27. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
[TBL] [Abstract][Full Text] [Related]
28. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
29. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
Nuyten DS; van de Vijver MJ
Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer bone metastasis: molecular basis of tissue tropism.
Kang Y
J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
[No Abstract] [Full Text] [Related]
31. Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
Lips EH; van Eijk R; de Graaf EJ; Oosting J; de Miranda NF; Karsten T; van de Velde CJ; Eilers PH; Tollenaar RA; van Wezel T; Morreau H
BMC Cancer; 2008 Oct; 8():314. PubMed ID: 18959792
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of a cancer somatic mutome.
Hernández P; Solé X; Valls J; Moreno V; Capellá G; Urruticoechea A; Pujana MA
Mol Cancer; 2007 Feb; 6():13. PubMed ID: 17280605
[TBL] [Abstract][Full Text] [Related]
33. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
34. A six-gene signature predicting breast cancer lung metastasis.
Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
[TBL] [Abstract][Full Text] [Related]
35. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
36. Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer.
Chiu SH; Chen CC; Lin TH
Artif Intell Med; 2008 Nov; 44(3):221-31. PubMed ID: 18678474
[TBL] [Abstract][Full Text] [Related]
37. Identification of differentially expressed genes in the high and low metastatic human ovarian cancer cell lines and analyses of their chromosomal localizations and functions.
Xu SH; Mu HZ; Gu LH; Zhu CH; Liu XL
Yi Chuan Xue Bao; 2006 Oct; 33(10):892-900. PubMed ID: 17046589
[TBL] [Abstract][Full Text] [Related]
38. [Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].
Bièche I; Lidereau R
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):142-52. PubMed ID: 8690862
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
40. Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes.
Wennmalm K; Calza S; Ploner A; Hall P; Bjöhle J; Klaar S; Smeds J; Pawitan Y; Bergh J
Genes Chromosomes Cancer; 2007 Jan; 46(1):87-97. PubMed ID: 17044045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
